Topics
November/December 2016 | Special Focus: The Year In Review
Recapping the Past 12 Months
the staff of Retina Today
November/December 2015 | Special Focus: The Year In Review
In the Rearview: Highlights of Happenings From 2015
A brief look at significant events, innovative products, and other notable headlines from the past year.
From the staff of Retina Today
September 11, 2026
Galimedix Therapeutics to Present Functional Feasibility Data from Phase 2 eDREAM study in GA at Euretina
September 10, 2026
Researchers Develop an AI System to Predict the Need for Therapy in Intermediate AMD
September 9, 2026
Johnson & Johnson Appoints Jacqueline Henderson Company Group Chair, Vision
FDA Accepts Nanoscope’s BLA for Optogenetic Gene Therapy Mogenry in Retinitis Pigmentosa
September 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
September 2026 Supplement
Editorially independent content supported with advertising by Eyepoint
Free Print Subscription
Email Newsletter
Conference Calendar
